Carriers of germline mutations in BRCA1, BRCA2 and PALB2 genes have been reported to have a higher risk of developing malignant abnormalities of the breast, colon, gynecological tissues, prostate and pancreas [22], but no association between germline mutations in these genes and non-melanoma skin cancers have been reported. This evidence concerns the gene PALB2 and skin neoplasm.